Palisade Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-11,698
| Closed | -$652K | – | 435 |
|
|
2017
Q2 | $652K | Sell |
11,698
-1,000
| -8% | -$55.7K | 0.02% | 361 |
|
|
2017
Q1 | $691K | Sell |
12,698
-2,450
| -16% | -$133K | 0.03% | 345 |
|
|
2016
Q4 | $885K | Buy |
15,148
+1,677
| +12% | +$98K | 0.03% | 341 |
|
|
2016
Q3 | $726K | Buy |
13,471
+9,750
| +262% | +$525K | 0.03% | 456 |
|
|
2016
Q2 | $274K | Hold |
3,721
| – | – | 0.01% | 504 |
|
|
2016
Q1 | $238K | Hold |
3,721
| – | – | 0.01% | 511 |
|
|
2015
Q4 | $256K | Sell |
3,721
-119
| -3% | -$8.19K | 0.01% | 503 |
|
|
2015
Q3 | $227K | Buy |
+3,840
| New | +$227K | 0.01% | 503 |
|
|
2013
Q3 | – | Sell |
-12,098
| Closed | -$541K | – | 442 |
|
|
2013
Q2 | $541K | Buy |
+12,098
| New | +$541K | 0.02% | 374 |
|